“dana-farber-cancer-institute” Archives

in
Entry Author Date Location
Making the Price Right: Ideas To Change Drug Costs Gain Momentum 04/05/16 National
Celldex’s Brain Cancer Vaccine Fails Key Phase 3 Test, Shares Fall 03/07/16 Boston
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More 03/03/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup 01/07/16 Boston
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy 12/07/15 Boston
With $55M, Neon Wants To Make the Cancer Vaccine “Problem” Personal 10/01/15 Boston
MD Anderson’s Chin Heads to UT to Lead Efforts to Fight Diabetes 04/02/15 Texas
Texas Cancer Center Seeks to Speed Discovery with Applied Research 12/03/14 Texas
Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials 10/27/14 Boston
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim 02/18/14 Boston
Red Sox Nutritionist on Sports, Stress, & Segterra (and World Series) 10/28/13 Boston
Celgene Nabs Option to Buy Acetylon for More Than $1.7B 07/29/13 Boston
Big Data Is BS in Healthcare. When Will It Become Real? 04/15/13 National
East Coast Biotech Roundup: Bristol-Myers, Syros, On-Q-ity, Ziopharm 04/12/13 Boston
Syros, a Whitehead and Dana-Farber Spinoff, Snags $30M For Cancer 04/11/13 Boston
Crowdfunding Is Coming to Biotech, so Get Ready for a Wild Ride 01/28/13 National
GNS to Use Big Data to Fight Multiple Myeloma 11/08/12 Boston
Bristol-Myers Wrangles Top Academics to Study Immunity in Cancer 06/07/12 New York
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 05/23/12 Seattle
Third Rock Looks to Fight Fat in a New Way, With Ember Therapeutics 12/15/11 Boston
Acetylon Adds $27M, Third Rock Leads Lotus Round, InfraReDx Gets $24M, & More Boston-Area Life Sciences News 07/01/11 Boston
Acetylon, Backed by Patriots Owner Bob Kraft, Snags $27M to Develop New Cancer Drugs 06/29/11 Boston
Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments 05/17/11 New York
Acetylon Nabs $4.9M for Myeloma Drug 05/11/11 Boston
KEW, Led by Millennium Co-Founder, Seeks to Bring Big-Time Cancer Care to Community Clinics 04/27/11 Boston
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41 02/10/11 Boston
Sanford-Burnham Strikes Deal With J&J, Second Big Pharma Alliance in a Month 01/17/11 San Diego
Page 1 of 3 next page »